Kamada Stock Discussion

$Kamada (KMDA.US)$ Press Release: Kamada Reports Strong First Quarter 2024 Financial Results With Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance

$Kamada (KMDA.US)$ ran?

$Kamada (KMDA.US)$ Honestly expecting/expected more here! the company had great earnings! They are overall profitable and now this binding agreement thats worth 180 million over the first 4 years! yup expected/looking for more?

$Kamada (KMDA.US)$ Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years 1 MINUTE AGO, 7:00 AM EST VIA GLOBENEWSWIRE

$Kamada (KMDA.US)$ reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. This is a 500 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $37.93 million which beat the analyst consensus estimate of $37.54 million by 1.06 percent. This is a 17.75 percent increase over sales of $32.22 million the same period last year.

$Kamada (KMDA.US)$ Kamada Says Cytogam Produced in Israel Plant Available for Sales in US
MT Newswires· 4 mins ago

$Kamada (KMDA.US)$ Kamada Announced Multiple Recent Achievements Related To Cytogam, Indicated For The Prophylaxis Of Cytomegalovirus Disease Associated With Transplantation Of Kidney, Lung, Liver, Pancreas, And Heart

$ADMA Biologics (ADMA.US)$ jumped by a healthy 68%, $iBio Inc (IBIO.US)$ rose by a handsome 28%, and $Kamada (KMDA.US)$ perked up as much as 24% in early morning action today as President announced that the Food and Drug Administration issued an emergency use authorization (EUA) for convalescent plasma therapy as a treatment for hospitalized COVID-19 patients on last Sunday.